Dissatisfaction with body image is common among men receiving androgen deprivation therapy (ADT), a new study has shown. Exercise is seen as a means to counterbalance the side effect of treatment and improve mood.
Response to desmopressin treatment for nocturnal enuresis in children appears to be compromised in the presence of constipation, particularly in children with severe enuresis and those prescribed low doses, as reported in a recent study.
Performing ultrasound-guided percutaneous nephrolithotomy (US-PCNL) either in prone or supine position is safe and effective as conventional PCNL, with the added benefit of eliminating radiation exposure and its hazards, according to a recent study.
Men working shifts outside of a normal 7 am to 6 pm work day who are at high risk of shift work disorder (SWD) appear to have worse lower urinary tract symptoms (LUTS) than their counterparts who are at low SWD risk, a study reports. However, nonstandard shift work in general is not associated with LUTS.
Stereotactic ablative radiotherapy has shown its capability as a treatment option in patients with renal cell carcinoma in a solitary kidney, achieving excellent oncologic outcomes as well as having an acceptable impact on renal function, according to an analysis of the IROCK (International Radiosurgery Oncology Consortium for Kidney) database.
A recent study has shown that procedural complications following percutaneous core renal mass biopsy are uncommon even with low serum platelets, a mildly increased international normalized ratio (INR) or when patients are on aspirin.
Patients with a positive post-treatment biopsy after external beam radiotherapy are at higher risk of distant metastasis and prostate cancer-related death, suggests a recent study. Positive post-treatment biopsies are more frequent in the setting of external beam radiotherapy alone without androgen deprivation therapy or in the presence of high-risk disease.
Cabozantinib is not better than mitoxantrone-prednisone at relieving pain in patients with metastatic castration-resistant prostate cancer (mCRPC) with symptomatic bone metastasis, a recent study suggests.
Treatment with abiraterone leads to fewer health-related quality of life (HRQoL) and mental health issues than enzalutamide in patients with metastatic castration-resistant prostate cancer (mCRPC), a recent study has found.
Overprescription of opioids after pelvic floor surgery and a provider education intervention have led to a substantial decrease in opioid prescribing without changing patient satisfaction with pain control, a recent study has found.
The aromatase inhibitor anastrozole shows promise in the treatment of children with congenital adrenal hyperplasia, reducing bone age advancement without adversely affecting bone mineral density and visceral adipose tissue, as shown in a recent study.
Men with metastatic hormone-sensitive prostate cancer (mHSPC) who receive testosterone suppression therapy may have a better survival outcome with the addition of enzalutamide over other non-steroidal anti-androgen (NSAA) therapies, according to the phase III ENZAMET* trial.